Key result
Hepatocyte growth factor levels are associated with heart failure severity in patients with Chagas' disease and dilated cardiomyopathy, but have poor prognostic value for mortality and heart transplant.
Why the study?
Does hepatocyte growth factor (HGF) level predict mortality and heart transplant necessity in patients with Chagas' disease and dilated cardiomyopathy?
Does hepatocyte growth factor (HGF) level predict mortality and heart transplant necessity in patients with Chagas' disease and dilated cardiomyopathy?
No takes yet. Share an insight, caveat, or question.
The prognostic value of HGF in heart failure appears to depend on the underlying etiology, with poor predictive value for mortality and transplant in Chagas' disease and idiopathic dilated cardiomyopathy despite elevated levels in advanced disease.
Fountoulaki et al. (2012) conducted an editorial in Heart failure. Hepatocyte growth factor (HGF) was evaluated. Hepatocyte growth factor levels are associated with heart failure severity in patients with Chagas' disease and dilated cardiomyopathy, but have poor prognostic value for mortality and heart transplant.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: